May 18, 2020 by Jeffrey Woldt
community pharmacy, coronavirus, COVID-19
May 18, 2020, Opinion

Entrenched assumptions about the role of community pharmacy are being uprooted by the COVID-19 crisis, and leaders of five of the nation’s largest retailers accelerated the process last month during a meeting with President Trump and the Coronavirus Task Force at the White House. The executives were there to lend support to the public-private partnership
September 4, 2018 by Mark Mechelse
community pharmacy, Global Market Development Center, Mark Mechelse
Issue 08-27-2018, Opinion

Retail in the future will look nothing like what we see today. A new role for physical retailers is long overdue, and only a few have satisfied the need for change. Historically, one of the primary challenges facing North American brick-and-mortar retail pharmacies and their suppliers has been the inability to encourage shoppers to purchase
March 19, 2018 by Jeffrey Woldt and Chain Drug Review
community pharmacy, Jeffrey Woldt, NACDS government affairs, NACDS RxImpact Day, National Association of Chain Drug Stores, pharmacy advocates, Tricare
2018, Issue 03-19-2018, Issues, Leading Headlines, Opinion

An understanding of the value created by the National Association of Chain Drug Stores’ annual RxImpact Day — for the policy makers and pharmacy advocates who participated, the pharmacy profession as a whole and, ultimately, patients across the country — came into sharp focus during the daylong series of meetings on Capitol Hill that is
January 15, 2018 by Geoff Walden and Chain Drug Review
AmerisourceBergen, Brian Nightengale, community pharmacy, Elevate Provider Network, Good Neighbor Pharmacy, independent pharmacies, J.D. Power U.S. Pharmacy Study
2018, Featured Articles, Issue 01-15-2018, Issues, Leading Headlines, News, Retail News

VALLEY FORGE, Pa. — AmerisourceBergen Corp.’s backing, combined with the entrepreneurship of independent pharmacies, has made the company’s Good Neighbor Pharmacy network an exemplar of high-touch service, says senior vice president of community and specialty pharmacy and Good Neighbor Pharmacy president Brian Nightengale. AmerisourceBergen’s support tools and personnel enhance the inherent ability of independents to
January 10, 2018 by B. Douglas Hoey and Chain Drug Review
B. Douglas Hoey, Community Care of North Carolina, community pharmacists, community pharmacy, CPESN–USA, DIR fees, IDNs, independent pharmacies, integrated delivery networks, National Community Pharmacists Association, NCPA, pharmacy benefit manager business model, pharmacy DIR legislation, prescription drug abuse
Opinion

Community pharmacy owners occupy a critical position in the pharmacy marketplace and, even more importantly, as health care providers in communities across the country. Most stakeholders in the profession understand the vital marketplace check and balance that independent businesses provide. If only two or three megachain drug stores existed, negotiations with payers would look very
December 11, 2017 by Chain Drug Review
antibiotic resistance, community pharmacy, Gigi Kwik Gronvall, Johns Hopkins Center for Health Security, Morning Consult, NACDS, National Association of Chain Drug Stores, opioid abuse epidemic, Steve Anderson
Issue 12-11-2017, News
ARLINGTON, Va. — Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores, and Gigi Kwik Gronvall, senior associate at the Johns Hopkins Center for Health Security, discussed the increasingly important role pharmacists are playing in public health in a recent op-ed published in Morning Consult. In the opinion piece,
October 23, 2017 by Jeffrey Woldt and Chain Drug Review
Amazon, community pharmacy, CVS Health, CVS Pharmacy, Jeff Bezos, Jeffrey Woldt, pharmacy market, prescription drug business, ScriptPath
2017, Featured Articles, Issue 10-23-2017, Issues, Leading Headlines, Opinion

Speculation about the possible entry of Amazon into the prescription drug business has been abundant in recent weeks. Financial analysts and journalists have generated a steady stream of reports about what is planned by the e-commerce powerhouse which, beginning with books 23 years ago, has succeeded in disrupting established business patterns in one merchandise category
August 19, 2017 by Jeffrey Woldt and Chain Drug Review
community pharmacy, Daymond John, FUBU, Jeffrey Woldt, Shark Tank
2017, Issue 08-21-2017, Issues, Opinion

Daymond John is the quintessential entrepreneur. Most widely known for his role on ABC TV’s “Shark Tank,” he put himself on the map in the business world with the creation of FUBU, the Hip Hop-inspired fashion brand that he started with a $40 investment and is now a $6 billion enterprise. John’s record of accomplishment
December 12, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, community pharmacy, pharmacy industry, Prime Therapeutics, Walgreens, Walgreens Boots Alliance
Featured Articles, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

DEERFIELD, Ill. — In a country where health care is rife with wasted time and money, Walgreens is committed to making pharmacy more efficient. One measure of the practice’s current inefficiency, says Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance Inc., is the large number of prescriptions that need additional authorization on the way
December 12, 2016 by Geoff Walden and Chain Drug Review
community pharmacy, Hy-Vee, Kristin Williams, NACDS Regional Chain Conference, National Association of Chain Drug Stores, retail pharmacy
2016, Issue 12-12-2016, Issues, News, Retail News

ARLINGTON, Va. — The upcoming NACDS Regional Chain Conference will be a fertile source of ideas for retail pharmacy, says Kristin Williams, senior vice president and chief health officer at Hy-Vee Inc. “The Regional Chain Conference is a wonderful venue for in-depth exchanges with both retail colleagues and suppliers,” says Williams, who is chairing the
October 10, 2016 by Jeffrey Woldt and Chain Drug Review
Association Leadership Awards, community pharmacy, Jeffrey Woldt, NACDS, National Association of Chain Drug Stores, retail pharmacy industry, Steve Anderson
2016, Issue 10-10-2016, Issues, Opinion

Steve Anderson joined a select group of business leaders last month when he was recognized as trade association CEO of the year. As only the third winner of the honor, part of the Association Leadership Awards sponsored by CEO Update, the National Association of Chain Drug Stores president and chief executive officer earned a distinction
August 3, 2016 by Todd Huseby, Bob O'Meara and Chain Drug Review
A.T. Kearney, Bob O’Meara, community pharmacy, pharmacy retailers, retail pharmacy industry, Todd Huseby
Leading Headlines, Opinion

With massive change in the retail pharmacy industry — including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which
May 3, 2016 by Chain Drug Review
any willing pharmacy, Bradley Arthur, community pharmacy, generic drug reimbursement, independent pharmacy, National Community Pharmacists Association, NCPA Congressional Summit, pharmacist provider status
Leading Headlines, Retail News

ALEXANDRIA, Va. — Later this month, hundreds of community pharmacists will head to Washington, D.C., to advocate for independent pharmacy and their patients at the National Community Pharmacists Association’s 2016 Congressional Pharmacy Summit. The two-day event, formerly known as the NCPA Legislative Conference, will feature community pharmacy and patient advocate Rep. Cathy McMorris Rodgers (R.,Wash.)
February 22, 2016 by Jeffrey Woldt and Chain Drug Review
community pharmacy, Eric Graf, Hy-Vee, Medicaid AMP, NACDS Regional Chain Conference, National Association of Chain Drug Stores, Randy Edeker, Ritzman Pharmacies
2016, Issue 02-22-2016, Issues, News

FORT LAUDERDALE, Fla. — Stakeholders in chain pharmacy understandably direct a lot of attention to the giants of the industry, such companies as CVS Health, Walgreens Boots Alliance, McKesson and Kroger. They shouldn’t lose sight, however, of the regional players that, in the aggregate, still account for a substantial part of the business and remain